Japanese pharmaceutical group Kobayashi Pharmaceutical said today it is investigating a fifth death that may be linked to some of its anti-cholesterol supplements, which contain red rice yeast and are at the center of a major health scandal in the country. The number of people hospitalized in Japan in this case has risen to 114, the group also said during a press conference. Patients mainly present with renal failure. A case of hospitalization in Taiwan, which may also be linked to Kobayashi Pharmaceutical's dietary supplements, was also reported yesterday, Thursday, by local media. If this link is confirmed, it would be the first known case outside of Japan. “I deeply apologize for the great concern we have caused,” the family-owned group's chairman, Akihiro Kobayashi, said today, bowing before the cameras along with other directors of his company in a sign of repentance. He also stated that he “regrets” the fact that the […]
Source: News Beast
With 6 years of experience, I bring to the table captivating and informative writing in the world news category. My expertise covers a range of industries, including tourism, technology, forex and stocks. From brief social media posts to in-depth articles, I am dedicated to creating compelling content for various platforms.
